Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Tick-Borne”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableLooking for participantsNCT07274046
What this trial is testing

Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic

Who this might be right for
Tick Borne Encephalitis (TBE)
Charles University, Czech Republic 209
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableActive Not RecruitingNCT05138055
What this trial is testing

The NOrwegian Tick-borne Encephalitis Study

Who this might be right for
Tick-Borne Encephalitis, European
Sykehuset Telemark 153
Large-scale testing (Phase 3)Study completedNCT00161824
What this trial is testing

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,800
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Not applicableLooking for participantsNCT03956446
What this trial is testing

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Who this might be right for
Tick Borne Encephalitis
University Medical Centre Ljubljana 80
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT01582698
What this trial is testing

TBE Seropersistence up to 10 Years After First Booster in Adults

Who this might be right for
Tick-borne Encephalitis (TBE)
Pfizer 243
Post-approval studies (Phase 4)UnknownNCT04573205
What this trial is testing

Primary TBE Vaccination for the Elderly

Who this might be right for
Tick-borne EncephalitisVaccine
Region Örebro County 90
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Not applicableStudy completedNCT06593249
What this trial is testing

Management of Tick-borne Encephalitis

Who this might be right for
Infectious Encephalitis
University Medical Centre Ljubljana 318
Testing effectiveness (Phase 2)Ended earlyNCT01031537
What this trial is testing

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Who this might be right for
Tick-Borne EncephalitisEncephalitis, Tick-BorneTick-Borne Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 69
Testing effectiveness (Phase 2)Study completedNCT00161798
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Not applicableLooking for participantsNCT03418441
What this trial is testing

Central Nervous System Infections in Denmark

Who this might be right for
Central Nervous System InfectionsBacterial MeningitisViral Meningitis+9 more
Aalborg University Hospital 1,900
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)Study completedNCT00503529
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 314
Next Page